Patents by Inventor Till Bussemer

Till Bussemer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • RECONSTITUTION DEVICE AND METHOD OF RECONSTITUTION
    Publication number: 20220192923
    Abstract: The present disclosure relates to a reconstitution device for reconstituting a medicament, the reconstitution device comprising: a base, a carrier movably arranged on the base, and a mount for a medicament container, wherein the mount is movably arranged on the carrier.
    Type: Application
    Filed: March 16, 2020
    Publication date: June 23, 2022
    Inventors: Claus Geiger, Sarah Helm, Kerstin Traub-Hoffmann, Till Bussemer, Britta Furtmann
  • Otamixaban formulations with improved stability
    Patent number: 9993464
    Abstract: The invention relates to a pharmaceutical composition comprising methyl (2R.3R)-2-{3-[amino(imino)methyl]benzyl}-3-{[4-(1-oxidopyridin-4-yl)benzoyl]amino}butanoate or a pharmaceutically acceptable salt thereof and a pharmaceutically acceptable acidic reacting compound or to an aqueous solution or dispersion of the composition as well as a process for the preparation of the same, methods of using such compositions to treat subjects suffering from conditions which can be ameliorated by the administration of an inhibitor of Factor Xa.
    Type: Grant
    Filed: September 14, 2016
    Date of Patent: June 12, 2018
    Assignee: SANOFI
    Inventors: Walter Kamm, Till Bussemer, Doris Andert, Bernd Kuehn, Ernst-Josef Todt
  • STABLE LIQUID FORMULATION FOR MONOCLONAL ANTIBODIES
    Publication number: 20180008707
    Abstract: The present invention concerns stable pharmaceutical compositions for monoclonal antibodies, for example IgG antibodies. The invention further relates to medicaments and treatments using the pharmaceutical compositions of the invention. Additionally, the invention relates to a kit comprising at least one of the pharmaceutical compositions of the invention and a method for reducing aggregation of antibodies.
    Type: Application
    Filed: February 12, 2016
    Publication date: January 11, 2018
    Inventors: Till BUSSEMER, Annette PIEPER, Dijana SAGI, Nina STREBE, Ahmed YOUSSEFF
  • OTAMIXABAN FORMULATIONS WITH IMPROVED STABILITY
    Publication number: 20170224668
    Abstract: The invention relates to a pharmaceutical composition comprising methyl (2R.3R)-2-{3-[amino(imino)methyl]benzyl}-3-{[4-(1-oxidopyridin-4-yl)benzoyl]amino} butanoate or a pharmaceutically acceptable salt thereof and a pharmaceutically acceptable acidic reacting compound or to an aqueous solution or dispersion of the composition as well as a process for the preparation of the same, methods of using such compositions to treat subjects suffering from conditions which can be ameliorated by the administration of an inhibitor of Factor Xa.
    Type: Application
    Filed: September 14, 2016
    Publication date: August 10, 2017
    Inventors: Walter KAMM, Till BUSSEMER, Doris ANDERT, Bernd KUEHN, Ernst-Josef TODT
  • OTAMIXABAN FORMULATIONS WITH IMPROVED STABILITY
    Publication number: 20140018398
    Abstract: The invention relates to a pharmaceutical composition comprising methyl (2R.3R)-2-{3-[amino(imino)methyl]benzyl}-3-{[4-(1-oxidopyridin-4-yl)benzoyl]amino}butanoate or a pharmaceutically acceptable salt thereof and a pharmaceutically acceptable acidic reacting compound or to an aqueous solution or dispersion of the composition as well as a process for the preparation of the same, methods of using such compositions to treat subjects suffering from conditions which can be ameliorated by the administration of an inhibitor of Factor Xa.
    Type: Application
    Filed: March 27, 2012
    Publication date: January 16, 2014
    Applicant: SANOFI
    Inventors: Walter Kamm, Till Bussemer, Doris Andert, Bernd Kuehn, Ernst-Josef Todt
  • OTAMIXABAN FORMULATIONS WITH IMPROVED STABILITY
    Publication number: 20120252852
    Abstract: The invention relates to a pharmaceutical composition comprising methyl (2R,3R)-2-{3-[amino(imino)methyl]benzyl}-3-{[4-(1-oxidopyridin-4-yl)benzoyl]amino}butanoate or a pharmaceutically acceptable salt thereof and a pharmaceutically acceptable acidic reacting compound or to an aqueous solution or dispersion of the composition as well as a process for the preparation of the same, methods of using such compositions to treat subjects suffering from conditions which can be ameliorated by the administration of an inhibitor of Factor Xa.
    Type: Application
    Filed: March 27, 2012
    Publication date: October 4, 2012
    Applicant: SANOFI
    Inventors: Walter KAMM, Till Bussemer, Doris Andert, Bernd Kühn, Ernst-Josef Todt